Bifogade filer
Kurs
-2,81%
Kurs
-2,81%
Open
3,40
High
3,48
Low
3,30
Close
3,46
Kursutveckling under dagen för detta pressmeddelande
(NOK).
Kalender
Est. tid* | ||
2026-06-12 | N/A | Årsstämma |
2026-02-12 | 08:40 | Bokslutskommuniké 2025 |
2025-11-13 | 08:40 | Kvartalsrapport 2025-Q3 |
2025-08-14 | 08:40 | Kvartalsrapport 2025-Q2 |
2025-06-13 | N/A | X-dag ordinarie utdelning INDCT 0.00 NOK |
2025-06-12 | N/A | Årsstämma |
2025-05-19 | 08:40 | Kvartalsrapport 2025-Q1 |
2025-02-13 | - | Bokslutskommuniké 2024 |
2024-11-14 | - | Kvartalsrapport 2024-Q3 |
2024-08-15 | - | Kvartalsrapport 2024-Q2 |
2024-06-17 | - | X-dag ordinarie utdelning INDCT 0.00 NOK |
2024-06-14 | - | Årsstämma |
2024-05-16 | - | Kvartalsrapport 2024-Q1 |
2024-02-15 | - | Bokslutskommuniké 2023 |
2023-11-15 | - | Kvartalsrapport 2023-Q3 |
2023-08-17 | - | Kvartalsrapport 2023-Q2 |
2023-06-21 | - | Årsstämma |
2023-06-15 | - | X-dag ordinarie utdelning INDCT 0.00 NOK |
2023-05-16 | - | Kvartalsrapport 2023-Q1 |
2023-02-15 | - | Bokslutskommuniké 2022 |
2022-11-15 | - | Kvartalsrapport 2022-Q3 |
2022-08-17 | - | Kvartalsrapport 2022-Q2 |
2022-05-12 | - | Kvartalsrapport 2022-Q1 |
2022-05-02 | - | X-dag ordinarie utdelning INDCT 0.00 NOK |
2022-02-15 | - | Bokslutskommuniké 2021 |
2021-11-01 | - | Kvartalsrapport 2021-Q3 |
2021-09-27 | - | Extra Bolagsstämma 2021 |
2021-08-16 | - | Kvartalsrapport 2021-Q2 |
2021-06-28 | - | Årsstämma |
2021-05-04 | - | X-dag ordinarie utdelning INDCT 0.00 NOK |
2021-05-03 | - | Kvartalsrapport 2021-Q1 |
2021-02-16 | - | Bokslutskommuniké 2020 |
2020-10-30 | - | Kvartalsrapport 2020-Q3 |
2020-08-14 | - | Kvartalsrapport 2020-Q2 |
2020-06-29 | - | Årsstämma |
2020-04-30 | - | Kvartalsrapport 2020-Q1 |
2020-02-04 | - | X-dag ordinarie utdelning INDCT 0.00 NOK |
2020-02-03 | - | Bokslutskommuniké 2019 |
2019-10-31 | - | Kvartalsrapport 2019-Q3 |
2019-08-15 | - | Kvartalsrapport 2019-Q2 |
2019-06-05 | - | X-dag ordinarie utdelning INDCT 0.00 NOK |
2019-04-30 | - | Kvartalsrapport 2019-Q1 |
2018-12-20 | - | Extra Bolagsstämma 2018 |
2018-04-13 | - | X-dag ordinarie utdelning INDCT 0.00 NOK |
2018-02-16 | - | Bokslutskommuniké 2017 |
2017-11-15 | - | Kvartalsrapport 2017-Q3 |
2017-08-15 | - | Kvartalsrapport 2017-Q2 |
2017-05-16 | - | Kvartalsrapport 2017-Q1 |
2017-02-17 | - | Bokslutskommuniké 2016 |
2016-09-30 | - | Kvartalsrapport 2016-Q2 |
2016-05-31 | - | Bokslutskommuniké 2015 |
2016-04-18 | - | Extra Bolagsstämma 2016 |
Beskrivning
Land | Norge |
---|---|
Lista | Euronext Growth Oslo |
Sektor | Informationsteknik |
Industri | Programvara |
2024-05-16 08:30:00
The Interim report for Q1 2024 for Induct AS has been approved by the Board of
Directors.
o Total revenues of NOK 5,7 million in Q1 2024 compared to NOK 5,9 million in Q1
2023.
o Platform revenues of NOK 5,0 million in Q1 2024 compared to NOK 5,2 million in
Q1 2023.
o Gross margin on platform revenues at 96,2%.
o EBITDA up by 39,4% from NOK 1,7 million in Q1 2023 to NOK 2,4 million in Q1
2024.
For further information, please contact: Synnøve Jacobsen, Chief Executive
Officer +47 99 41 54 47 sj@induct.net
About Induct Induct AS was established in 2007 and was a first mover in the
development of software as a service (SaaS) for managing innovation efforts in,
and between, organizations. Our software has enabled more than 350 organizations
worldwide to release the potential that lies in identifying new and good ideas
through innovation engagement and realizing the benefits of turning good ideas
into new ways of thinking, acting, organizing, and working.
In 2020, Induct took a new step on its journey as a knowledge empowerment
provider. We launched a new digital platform - induct.net - where work and
collaboration are taken to a new level for organizations and individuals alike.
By removing unnecessary and unhelpful barriers to collaboration, the platform is
a unique facilitator of knowledge development and management, sharing and
empowerment within organizations, in collaborative networks, and in ecosystems.
Induct has offerings in three main segments: 1) Patient data and patient
management, 2) Grants and grant management and 3) Innovation and innovation
management.
Want to learn more? Visit us at induct.net